← Back to headlines
Novo Nordisk Announces FDA Approval for Sogroya
Novo Nordisk A/S has announced that its drug Sogroya received FDA approval for three new indications.
1 Mar, 09:27 — 1 Mar, 09:27
Sources
Showing 1 of 1 sources
Novo Nordisk A/S has announced that its drug Sogroya received FDA approval for three new indications.
